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Abstract Crystallographic and mutagenesis tudies have un- 
ravelled the general features of the allosteric transition mechan- 
ism in pyruvate kinase. The enzyme displays a dramatic 
conformational change in going from the T- to the R-state. All 
three domains forming each subunit of the tetrameric enzyme 
undergo simultaneous and concerted rotations, in such a way that 
all subunit and domain interfaces are modified. This mechanism 
is unprecedented since in all tetrameric allosteric enzymes, 
characterised at atomic resolution, at least one of the domain or 
subunit interfaces remains unchanged on the T- to R-state 
transition. The molecular mechanism of allosteric regulation here 
proposed provides a rationale for the effect of single site 
mutations observed in the human erythrocyte pyruvate kinase 
associated with a congenital anaemia. 
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whereas the L PK is additionally controlled by phosphoryla- 
tion on a N-terminal Ser residue which causes a decrease in 
the affinity for the PEP and FBP activators [3]. More unusual 
is the muscle M1 protein [6] which is the only known PK 
displaying hyperbolic kinetics and no allosteric ontrol. 
While the structure of the cat M1 isoenzyme was deter- 
mined by Muirhead and coworkers everal years ago [6], little 
information was available about the allosteric transition in 
PK. Substantial progress in this respect has been observed 
over the last few years with further refinement of the M1 
isoenzyme model [7], and with the X-ray structure determina- 
tion of the FBP-dependent E. coli PK, in the inactive T-state 
[8]. Furthermore, insight into the enzyme regulatory proper- 
ties has been provided by mutagenesis studies [9] and by the 
characterisation f several R PK variants from patients with 
congenital anaemia [10]. 
1. Introduction 
The final step in the glycolytic pathway is the conversion of 
phosphoenolpyruvate (PEP) to pyruvate with the synthesis of 
one ATP molecule: 
PEP + Mg - ADP + H + Mg~+'K+ Mg - ATP + pyruvate 
2. Overall architecture 
The X-ray diffraction studies on cat M1 PK [6] have re- 
vealed the complex molecular architecture of the enzyme, 
which is a tetramer of four identical subunits, each encom- 
passing three domains (see Fig. 2A,B): (i) the A domain, with 
the classic (13/~)8 barrel topology observed in several unrelated 
proteins; (ii) the small B domain, characterised by an irregular 
The reaction is catalysed by pyruvate kinase (PK), which 
requires for its activity both monovalent and divalent cations 
[1,2]. PK is a typical allosteric enzyme [3], and plays a major 
role in the control of the metabolic flux from fructose-l,6- 
bisphosphate (FBP) to pyruvate, in the second section of gly- 
colysis (see Fig. 1). Furthermore, the reaction product pyru- 
vate is involved in such a variety of metabolic pathways that 
PK may be considered a key enzyme not only for the glyco- 
lytic pathway but also for the entire cellular metabolism. 
PK from prokaryotes i normally activated homotropically 
by PEP and heterotropically b sugars bearing either one (i.e. 
ribose-phosphate) or two (i.e. FBP) phosphate groups. FBP is 
also the activator of nearly all characterised eukaryotic PK 
molecules, even though in trypanosomes the enzyme activator 
is fructose-2,6-bisphosphate [4]. More sophisticated is the con- 
trol in mammals, where four PK isoenzymes are expressed in 
a tissue-specific manner [3,5]: M1 PK present mostly in the 
skeletal muscle; M2 PK in many tissues such as kidney, in- 
testine, lung fibroblasts, testis, and stomach; L PK mostly in 
the liver; R PK exclusively in the red blood cells. The FBP- 
dependent M1 and R isoenzymes hare allosteric properties 
similar to those of the other eukaryotic PK molecules, 
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Fig. 1. The role of pyruvate kinase in the regulation of glycolysis. 
PK controls the second part of the pathway being activated by 
phosphoenolpyruvatc andfructose-l,6-bisphosphate. This metabolite 
is produced in the reaction catalysed by phosphofructokinase, the 
other major regulatory glycolytic enzyme, whose activity is inhibited 
by phosphoenolpyruvate andactivated by fructose-6-phosphate. 
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13 barrel; (iii) the C-terminal C domain with a ~ topology. A 
fourth small N-terminal domain, absent in PK from bacteria, 
is formed by a helix-turn-helix motif. The recent X-ray ana- 
lysis of the rabbit M1 protein in complex with pyruvate based 
on crystals grown from polyethylene glycol [7] has identified 
,a. 
the residues forming the PEP and cation binding sites. These 
are located in the cleft between the A and B domains, and are 
mostly provided by the sixth and eighth loops of the A do- 
main (13/O0s barrel (Fig. 2A). 
In the functional enzyme the four subunits are intimately 
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Fig. 2. (A) The subunit of the E. coli T-state PK [8]. Domains A, B and C are shown in green, blue and red, respectively. The spheres outline 
the residues whose mutation in the human R PK causes the non-spherocytic haemolytic anaemia ([16-18] and references therein). The amino 
acid sequence identity between human R and E. coli PK is 51%. The sequence number of the R PK residues is shown in brackets. (B) Subunit 
arrangement in the tetrameric E. coli T-state PK (left) and the M 1 R-like PK (right). The domains are coloured as in (A). The small helix- 
turn-helix N-terminal domain of the M1 protein is depicted in yellow. Produced with MOLSCRIPT [23]. 
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Fig. 2. (continued). 
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Fig. 3. Schematic representation f the domain and subunit rotations occurring on the T- to R-state PK transition. The T-state structure is on 
the left. 
associated to form a tetramer of 222 symmetry. Extensive in- 
teractions mainly between the A and C domains of two oppo- 
site subunits tabilise the oligomeric assembly (Fig. 2A,B). 
3. The allosteric transition 
M1 PK is not allosterically regulated such that the enzyme 
is thought o be a sort of allosterically ocked 'natural' mutant 
adopting an active R-like conformation [11]. This is supported 
by the fact that the non-allosteric M1 and the allosteric M2 
isoenzymes, which derive from alternative splicing of the same 
precursor RNA [12], differ in their primary structures only for 
a stretch of 45 amino acids, 21 of which are substituted. On 
this basis, examination of the recently determined T-state 
E. coli PK structure, and its comparison with the M1 R-state 
conformation [8], has allowed us to analyse the general fea- 
tures of the allosteric transition mechanism. Particularly, it 
has revealed that PK undergoes a dramatic onformational 
change on switching from the low affinity T-state to the 
high affinity R-state conformation (Fig. 2B). A combination 
of two kinds of movements is observed: (i) the rotation of the 
B and C (17 ° and 15 °, respectively) domains within every 
subunit, and (ii) a 16 ° rotation of every subunit within the 
tetramer (Fig. 3). The enzyme activation process, therefore, 
appears to involve a combination of domain and subunit ro- 
tations, suggesting that the PK tetramer can be portrayed as a 
modular protein in which all 12 domains are capable of un- 
dergoing highly concerted motions. This notion is further sup- 
ported by the observation that the structure of the individual 
domains is not significantly altered by their movements, im- 
plying that they rotate as rigid bodies and are connected to 
each other by highly flexible hinges. 
The determination f the E. coli PK T-state structure has 
been hampered by an intrinsic non-isomorphism of the crys- 
tals [8], which, even when grown in the same experiment, may 
exhibit large variability in their X-ray diffraction pattern. 
Analysis of the numerous X-ray diffraction data sets collected 
during structure determination has revealed that the B-do- 
main varies its orientation from crystal to crystal, thereby 
causing non-isomorphism. In this respect, variability of the 
B domain orientation has been observed also in the cat [6] 
and rabbit [7] M1 PK structures, further emphasising the en- 
zyme flexibility and modularity, two key properties which are 
at the heart of the regulatory mechanism. Moreover, these 
independent observations suggest hat the T- and R-states 
probably represent, in PK, an ensemble of conformations 
rather than a single well defined structure. In keeping with 
this hypothesis, fluorescence quenching experiments on yeast 
PK have led to a model for cooperativity which incorporates 
an intermediate state R', with properties different from those 
of the T- and R-states [13]. 
4. Catalytic centre and effector binding site 
The comparison of the M1 R-state and E. coli T-state PK 
structures [8] shows that domain and subunit rotations are 
coupled to a defined conformational change in the enzyme 
active site. Upon R- to T-state transition, loop 6 of the A 
domain (~/C0s barrel (Fig. 2A) shifts by about 1 ,~, triggering 
a distortion of the PEP binding site, which is the likely cause 
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of the low substrate affinity of the T-state enzyme (for details 
see [8]). In a similar way, the effector binding pocket under- 
goes a structural transition. Mutagenesis and chemical mod- 
ification [9,14] studies have revealed that the enzyme activator 
binds in a cleft between the A and C domains, characterised 
by a cluster of positively charged residues. In the low affinity 
T-state, upon rotation of the C domain, the cleft shrinks pre- 
venting effector binding. A better characterisation f the ac- 
tive and allosteric site conformational changes, and of their 
coupling to the domain rotations, must of course await the 
structure determination of the R-state PK in complex with 
activator and with the PEP and ADP substrates. These struc- 
tural studies will be complemented by site-directed mutagen- 
esis experiments aimed at the creation of mutants with altered 
allosteric properties [15]. The genes of PK from E. coli (Va- 
lentini et al., unpublished), yeast [13] and B. stearothermophi- 
lus [9] have been cloned and overexpressed, paving the way 
for this approach. 
5. Molecular abnormalities and anaemia 
Deficiency of the human erythrocyte R PK is the most 
common cause of the hereditary non-spherocytic haemolytic 
anaemia [10], a congenital disease with severe clinical mani- 
festations, leading to occasional death in the neonatal period. 
Over the past years, the PK gene of many patients has been 
sequenced, revealing that in most cases a single site mutation 
is causing the enzyme deficiency ([16-18] and references there- 
in). The effect of many of these pathological PK mutations 
can now be rationalised on the basis of the described allosteric 
transition mechanism. In fact, the amino acid substitutions so
far detected appear to cluster in three well defined regions of 
the structure (Fig. 2A): (i) the hydrophobic ore of the A 
domain (13/e~)s barrel; (ii) the A domain helices 6, 7 and 8, 
which are involved in the quaternary structure intersubunit 
association; and (iii) the interface between the A and C do- 
mains, where the effector binding site is located. The most 
frequent pathological mutation (Arg 51° ~ Gin, R PK number- 
ing) occurs in this third region and causes an affinity decrease 
for FBP and PEP, but not for the non-allosteric ADP sub- 
strate, suggesting that the mutation primarily affects the equi- 
librium between the R and T forms. In this context, it is 
remarkable that the severity of the anaemia ppears to be 
correlated with the level of impairment in the allosteric re- 
sponse, rather than with the decreased catalytic efficiency of 
the mutated enzyme [17,18]. These data clearly emphasise the 
centrality and pivotal role of PK in the regulation of the 
cellular metabolism. 
6. Conclusions 
The molecular mechanism for the allosteric transition 
mechanism of PK is unique in that it involves the simulta- 
neous rotation of 12 domains and the consequent alteration of 
all domain and subunit interfaces. Such a mechanism is un- 
precedented since in all tetrameric ooperative proteins, of 
known three-dimensional structure, at least one of these inter- 
faces remains unmodified on allosteric activation [19]. In most 
cases, like tetrameric fructose-l,6-bisphosphatase [20] or phos- 
phofructokinase [21], the transition is based on the rotation of 
one dimer with respect o the other, such that the intersubunit 
contacts within each of the two rotating bodies are preserved. 
Also the haemoglobin R- to T-state transition proceeds, at 
least in general terms, through this mechanism [19]. More 
complex is the case of bacterial lactate dehydrogenase [22], 
which displays rotation of the four subunits, without, how- 
ever, any significant mutual reorientation of the two domains 
forming each monomer. 
The large domain and subunit rotations observed in PK 
represent a striking example of a flexible protein architecture 
developed by nature for the purpose of complex and strict 
enzyme regulation. More details of the mechanism by which 
this large conformational change is coupled to the alteration 
of the active and allosteric sites remain, however, to be eluci- 
dated. Consideration of the available xperimental evidences 
suggests that we may have sampled only few of the possible 
enzyme conformations: PK may well reserve more twists and 
turns for the future. 
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